132 related articles for article (PubMed ID: 27056726)
1. Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats.
Gao JH; Wen SL; Tong H; Wang CH; Yang WJ; Tang SH; Yan ZP; Tai Y; Ye C; Liu R; Huang ZY; Tang YM; Yang JH; Tang CW
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G962-72. PubMed ID: 27056726
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes.
Wen SL; Gao JH; Yang WJ; Lu YY; Tong H; Huang ZY; Liu ZX; Tang CW
J Gastroenterol Hepatol; 2014 Nov; 29(11):1932-42. PubMed ID: 24909904
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclooxygenase-2 enhanced intestinal epithelial homeostasis via suppressing β-catenin signalling pathway in experimental liver fibrosis.
Zhang L; Tai Y; Zhao C; Ma X; Tang S; Tong H; Tang C; Gao J
J Cell Mol Med; 2021 Aug; 25(16):7993-8005. PubMed ID: 34145945
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats.
Tang S; Huang Z; Jiang J; Gao J; Zhao C; Tai Y; Ma X; Zhang L; Ye Y; Gan C; Su W; Jia X; Liu R; Wu H; Tang C
Life Sci; 2021 May; 272():119203. PubMed ID: 33577848
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.
Gao JH; Wen SL; Yang WJ; Lu YY; Tong H; Huang ZY; Liu ZX; Tang CW
PLoS One; 2013; 8(7):e69309. PubMed ID: 23922700
[TBL] [Abstract][Full Text] [Related]
6. Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Minutoli L; Arcoraci V; Squadrito G; Macrì A; Squadrito F; Altavilla D
Eur J Pharmacol; 2016 Oct; 789():152-162. PubMed ID: 27450484
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib Alleviates Memory Deficits by Downregulation of COX-2 Expression and Upregulation of the BDNF-TrkB Signaling Pathway in a Diabetic Rat Model.
Yang Y; Gao L
J Mol Neurosci; 2017 Jun; 62(2):188-198. PubMed ID: 28466254
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 up-regulates ataxia telangiectasia and Rad3 related through extracellular signal-regulated kinase activation.
Kim YM; Lee EJ; Park SY; Cho KH; Kim JY; Pyo H
Mol Cancer Res; 2009 Jul; 7(7):1158-68. PubMed ID: 19584262
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line.
Kondreddy VK; Kamatham AN
Immunopharmacol Immunotoxicol; 2016; 38(2):153-61. PubMed ID: 26954392
[TBL] [Abstract][Full Text] [Related]
10. Regulation of liver regeneration by prostaglandin E
Mohamed YS; Abdelsalam RM; Attia AS; Abdel-Aziz MT; El-Tanbouly DM
Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1437-1446. PubMed ID: 32162076
[TBL] [Abstract][Full Text] [Related]
11. Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver.
Lu CH; Hung YJ; Hsieh PS
Eur J Pharmacol; 2016 Oct; 789():60-67. PubMed ID: 27397427
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury.
Harris TR; Kodani S; Rand AA; Yang J; Imai DM; Hwang SH; Hammock BD
Mol Pharmacol; 2018 Aug; 94(2):834-841. PubMed ID: 29844231
[TBL] [Abstract][Full Text] [Related]
13. Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat.
Chávez E; Segovia J; Shibayama M; Tsutsumi V; Vergara P; Castro-Sánchez L; Salazar EP; Moreno MG; Muriel P
Liver Int; 2010 Aug; 30(7):969-78. PubMed ID: 20524983
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats.
Gao JH; Wen SL; Feng S; Yang WJ; Lu YY; Tong H; Liu R; Tang SH; Huang ZY; Tang YM; Yang JH; Xie HQ; Tang CW
Angiogenesis; 2016 Oct; 19(4):501-11. PubMed ID: 27380212
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.
Lorenzo-Zúñiga V; Rodríguez-Ortigosa CM; Bartolí R; Martínez-Chantar ML; Martínez-Peralta L; Pardo A; Ojanguren I; Quiroga J; Planas R; Prieto J
Gut; 2006 Sep; 55(9):1306-12. PubMed ID: 16434425
[TBL] [Abstract][Full Text] [Related]
16. Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis.
Short SS; Wang J; Castle SL; Fernandez GE; Smiley N; Zobel M; Pontarelli EM; Papillon SC; Grishin AV; Ford HR
Lab Invest; 2013 Dec; 93(12):1265-75. PubMed ID: 24126890
[TBL] [Abstract][Full Text] [Related]
17. Bile acids increase alveolar epithelial permeability via mitogen-activated protein kinase, cytosolic phospholipase A2 , cyclooxygenase-2, prostaglandin E2 and junctional proteins.
Su KC; Wu YC; Chen CS; Hung MH; Hsiao YH; Tseng CM; Chang SC; Lee YC; Perng DW
Respirology; 2013 Jul; 18(5):848-56. PubMed ID: 23521748
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways.
Lei Q; Qiang F; Chao D; Di W; Guoqian Z; Bo Y; Lina Y
Int J Mol Med; 2014 Dec; 34(6):1629-39. PubMed ID: 25318952
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain.
Guo JY; Li CY; Ruan YP; Sun M; Qi XL; Zhao BS; Luo F
Eur J Pharmacol; 2009 Jun; 612(1-3):54-60. PubMed ID: 19356723
[TBL] [Abstract][Full Text] [Related]
20. Acute changes in colonic PGE
Yun C; Dashwood WM; Li L; Yin T; Ulusan AM; Shatzer K; Gao S; Ruan KH; Hu M
Inflamm Res; 2020 Jan; 69(1):131-137. PubMed ID: 31797003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
